Barclays Capital has launched limit orders on BARX Fixed Income to the firm’s online electronic trading platform for fixed income securities and derivatives.
Limit Orders is a fully automated service which allows clients to buy or sell government bonds or interest-rate swaps when a certain price is reached in the market, explained the company’s announcement yesterday. Using an electronic trade ticket, clients can simply choose to either execute at the current price or leave an instruction for execution at a different target price. When the target price is hit, the limit order is then executed through the automated system in real time.
“As a global leader in fixed income, we are dedicated to providing our clients with innovative electronic services that enhance their trading experience,” commented Harry Harrison, head of rates trading at Barclays Capital. “With the changing regulatory landscape and greater focus on electronic trading, coupled with the increasingly complex execution demands of our clients, we believe this additional functionality enriches the BARX offering and takes our ability to serve our clients to the next level,” further stated Harrison in the release.
This new limit order functionality provides clients with the ability to effectively manage their strategic trades and access pools of liquidity, electronically, the brokerage firm said. Andrew Challis, head of global rates e-distribution, said the addition of Limit Orders to BARX Fixed Income, give clients even more control over their electronic execution of government bonds and interest rates swaps. “Clients are now able to use BARX Fixed Income to manage their trading strategies, in addition to their instant execution needs.”
Limit Orders are now live and are being used by BARX Fixed Income clients.
Ivy is Editor-at-Large for Advanced Trading and Wall Street & Technology. Ivy is responsible for writing in-depth feature articles, daily blogs and news articles with a focus on automated trading in the capital markets. As an industry expert, Ivy has reported on a myriad ... View Full Bio